# CVS HEALTH CORPORATION (CVS) FY2026 Q1 Balance Sheet

- Company: CVS HEALTH CORPORATION (CVS)
- Period: As of 2026-03-31
- Filing: Q1 FY2026 10-Q, filed 2026-05-06, accession number 0000064803-26-000052
- Page: https://plicit.ai/financials/cvs/fy2026-q1-balance-sheet
- Chart image: https://plicit.ai/charts/cvs-fy2026-q1-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 252,974,000,000 US dollars
- **Current assets**: 74,817,000,000 US dollars
- **Non-current assets**: 178,157,000,000 US dollars
- **Liabilities**: 175,337,000,000 US dollars
- **Current liabilities**: 86,406,000,000 US dollars
- **Non-current liabilities**: 88,931,000,000 US dollars
- **Equity**: 77,637,000,000 US dollars
- **Noncontrolling interest**: 181,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Accounts receivable, net**: 40,992,000,000 US dollars
- **Inventories**: 17,770,000,000 US dollars
- **Cash and cash equivalents**: 9,542,000,000 US dollars
- **Other current assets**: 4,253,000,000 US dollars
- **Investments**: 2,260,000,000 US dollars
- **Goodwill**: 85,478,000,000 US dollars
- **Long-term investments**: 32,407,000,000 US dollars
- **Intangible assets, net**: 25,070,000,000 US dollars
- **Operating lease right-of-use assets**: 14,741,000,000 US dollars
- **Property and equipment, net**: 13,037,000,000 US dollars
- **Other assets**: 7,424,000,000 US dollars
- **Pharmacy claims and discounts payable**: 26,149,000,000 US dollars
- **Accrued expenses and other current liabilities**: 22,258,000,000 US dollars
- **Accounts payable**: 16,922,000,000 US dollars
- **Health care costs payable**: 15,518,000,000 US dollars
- **Current portion of long-term debt**: 2,580,000,000 US dollars
- **Current portion of operating lease liabilities**: 1,904,000,000 US dollars
- **Other insurance liabilities**: 1,075,000,000 US dollars
- **Long-term debt**: 60,531,000,000 US dollars
- **Long-term operating lease liabilities**: 13,330,000,000 US dollars
- **Other long-term liabilities**: 6,707,000,000 US dollars
- **Other long-term insurance liabilities**: 4,592,000,000 US dollars
- **Deferred income taxes**: 3,771,000,000 US dollars
- **Retained earnings**: 63,282,000,000 US dollars
- **Common stock, par value $0.01: 3,200 shares authorized; 1,788 shares issued and 1,273 shares outstanding as of March 31, 2026 and 1,787 shares issued and 1,271 shares outstanding as of December 31, 2025 and capital surplus**: 50,679,000,000 US dollars
- **Accumulated other comprehensive income**: 201,000,000 US dollars
- **Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding**: 0 US dollars
- **Noncontrolling interests**: 181,000,000 US dollars
- **Treasury stock, at cost: 515 and 516 shares as of March 31, 2026 and December 31, 2025**: negative 36,706,000,000 US dollars
- **Gross equity (calculated)**: 114,343,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.